Related Experiment Video
Updated: Aug 5, 2026

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
Cellular Retinoic Acid-Binding Protein 2 Promotes Ischemia-Induced Cardiac Fibroblast Activation and Fibrosis Through
Zhenyang Su1, Hui Shen1, Jinyu Sun1
1Department of Cardiology The First Affiliated Hospital with Nanjing Medical University Nanjing China.
Background:
Cardiac fibrosis is a hallmark of ischemic heart failure and is driven by activated myofibroblasts. DNA damage and defective repair promote fibroblast activation, yet the upstream regulators that couple DNA damage responses to profibrotic remodeling remain unclear.
Methods:
Single-cell RNA sequencing data sets from human ischemic cardiomyopathy were analyzed to identify fibroblast-enriched candidate genes. In vivo, Postn promoter-driven adeno-associated viruses were used to knock down or overexpress CRABP2 (cellular retinoic acid-binding protein 2) in an isoproterenol-induced mouse model, followed by assessment of ventricular function and fibrosis. In vitro, neonatal cardiac fibroblasts were subjected to CRABP2 gain or loss of function and TGF-β (transforming growth factor-β) stimulation. Mechanistic studies combined RNA sequencing, immunoprecipitation-mass spectrometry, structural modeling, γ-H2AX staining, comet assays, and MRE11/MRE11-RAD50-NBS1 (MRN) perturbation.
Results:
Single-cell analyses identify CRABP2 as a fibroblast-enriched gene upregulated in profibrotic fibroblast subsets in human ischemic hearts. In vivo, CRABP2 knockdown in Postn+ myofibroblasts preserves left ventricular function and attenuates interstitial fibrosis, whereas CRABP2 overexpression exacerbates dysfunction and fibrosis in isoproterenol-treated mice. In vitro, CRABP2 promotes TGF-β-induced fibroblast migration, proliferation, activation, and collagen production. Mechanistically, CRABP2 binds MRE11, suppresses MRN-ATM-CHK2 signaling, and enhances DNA damage accumulation. Inhibiting or silencing MRE11 abrogates the antifibrotic and cardioprotective effects of CRABP2.
Conclusions:
CRABP2 drives profibrotic cardiac fibroblast activation by inhibiting MRE11/MRN-mediated DNA repair. The CRABP2-MRE11-MRN axis represents a potential therapeutic target for limiting fibrotic remodeling in ischemic heart failure.
Insights
Cellular retinoic acid-binding protein 2 (CRABP2) drives cardiac fibrosis by impairing DNA repair in heart failure. Targeting the CRABP2-MRE11-MRN pathway may limit profibrotic remodeling.
Area of Science:
- Cardiology
- Molecular Biology
- Genetics
Background:
- Cardiac fibrosis, a key feature of ischemic heart failure, stems from activated myofibroblasts.
- While DNA damage and repair defects contribute to fibroblast activation, upstream regulators remain unidentified.
Purpose of the Study:
- To investigate the role of cellular retinoic acid-binding protein 2 (CRABP2) in cardiac fibroblast activation and profibrotic remodeling.
- To elucidate the molecular mechanisms by which CRABP2 influences DNA damage response and cardiac fibrosis.
Main Methods:
- Single-cell RNA sequencing of human ischemic cardiomyopathy samples to identify fibroblast-enriched genes.
- In vivo studies using adeno-associated viruses to modulate CRABP2 in a mouse model of cardiac dysfunction.
- In vitro experiments with neonatal cardiac fibroblasts to assess CRABP2 function under transforming growth factor-beta (TGF-β) stimulation.
- Mechanistic investigations including RNA sequencing, immunoprecipitation-mass spectrometry, and DNA damage assays.
Main Results:
- CRABP2 was identified as a fibroblast-enriched gene upregulated in profibrotic subsets within human ischemic hearts.
- CRABP2 knockdown preserved cardiac function and reduced fibrosis in mice, while overexpression exacerbated these conditions.
- In vitro, CRABP2 enhanced TGF-β-induced fibroblast migration, proliferation, activation, and collagen production.
- CRABP2 was found to bind MRE11, suppress MRN-ATM-CHK2 signaling, and increase DNA damage accumulation.
Conclusions:
- CRABP2 promotes profibrotic cardiac fibroblast activation by inhibiting MRE11/MRN-mediated DNA repair.
- The CRABP2-MRE11-MRN axis presents a potential therapeutic target for mitigating fibrotic remodeling in ischemic heart failure.
Related Concept Videos
MAPK Signaling Cascades
Regulation of Angiogenesis and Blood Supply
Intracellular Signaling Affects Focal Adhesions
Some...
Regulation of the Unfolded Protein Response